Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Relapsing polychondritis treated with dapsone

J Martin, H H Roenigk, W Lynch

    Archives of Dermatology
    |September 1, 1976
    PubMed
    Summary

    Dapsone offers a promising treatment for relapsing polychondritis, a rare immune disorder. This study highlights dapsone as a potentially preferred alternative to corticosteroids for managing this severe cartilage inflammation.

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Problems + Solutions.

    Postgraduate medicine·2016
    Same author

    Effects of acitretin on the liver.

    Journal of the American Academy of Dermatology·1999
    Same author

    Acitretin combination therapy.

    Journal of the American Academy of Dermatology·1999
    Same author

    Treatment of multiple facial syringomas with the carbon dioxide (CO2) laser.

    Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]·1999
    Same author

    Dermatologic manifestations of gastrointestinal disorders.

    Gastroenterology clinics of North America·1999
    Same author

    Usefulness of the staged excision for lentigo maligna and lentigo maligna melanoma.

    Journal of the American Academy of Dermatology·1998

    Area of Science:

    • Immunology
    • Rheumatology
    • Pathology

    Background:

    • Relapsing polychondritis (RP) is a rare, potentially fatal autoimmune disease.
    • The exact cause of RP is unknown, but it's suspected to involve autoantibodies targeting mucopolysaccharides.
    • Cartilage inflammation in RP may be sustained by proteolytic processes.